Phibro Animal Health | PAHC - Current Liabilities


Phibro Animal Health reported $282.37M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Align Technology USD 1.92B 46.45M Dec/2025
ANI Pharmaceuticals USD 278.11M 7.56M Dec/2025
Assertio Holdings USD 166.78M 34.25M Sep/2025
Aurora Cannabis CAD 145.94M 21.82M Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Canopy Growth CAD 98.29M 17.19M Dec/2025
Corcept Therapeutics USD 166.08M 6.18M Dec/2025
Eli Lilly USD 35.23B 4.91B Dec/2025
Henry Schein USD 3.23B 79M Dec/2025
Idexx Laboratories USD 1.15B 103M Dec/2025
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Merck USD 28.63B 2.59B Sep/2025
Nektar Therapeutics USD 66.34M 5.05M Sep/2025
Pacira USD 120.59M 13.51M Dec/2025
Phibro Animal Health USD 282.37M 12.23M Dec/2025
Prestige Brands USD 139.56M 4.95M Dec/2025
Supernus Pharmaceuticals USD 338.17M 7.54M Dec/2025
Zoetis USD 2.24B 428M Dec/2025